找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Stem Cells for Cancer and Genetic Disease Treatment; Phuc Van Pham,Ahmed El-Hashash Book 2018 Springer Nature Switzerland AG 2018 progenit

[復(fù)制鏈接]
樓主: 和善
21#
發(fā)表于 2025-3-25 04:37:21 | 只看該作者
Mesenchymal Stem Cell Based Approaches for Systemic Lupus Erythematosus Immunotherapyhem a very promising new choice for treatment of severe refractory SLE. In this chapter, we provide a brief overview of MSCs treatment in SLE and describe current knowledge of the mechanisms by which they play parts in treating the disease, for better understanding of the pathogenesis and therapy for SLE.
22#
發(fā)表于 2025-3-25 10:37:52 | 只看該作者
23#
發(fā)表于 2025-3-25 12:04:17 | 只看該作者
Mesenchymal Stem Cells as Vectors for Cancer Therapyd on this property, MSCs have been used as vectors to deliver anti-cancer agents to tumors. To date, MSCs have been modified to express some factors or agents, including interleukin (IL)-12, IL-14, IFN-beta, IFN-gamma, TRAIL, and suicide genes/enzymes. Currently, MSCs are being modified to deliver o
24#
發(fā)表于 2025-3-25 19:02:12 | 只看該作者
Stem Cells Treatment to Combat Cancer and Genetic Disease: From Stem Cell Therapy to Gene-Editing Cogenerate blood and immune system, after a course of high-dose chemotherapy, some cancers as well as the use of these cells for other cell recoveries have been proven. The progress of medical science in the treatment of cancer patients and patient with various genetic diseases in recent years has bee
25#
發(fā)表于 2025-3-25 20:34:15 | 只看該作者
26#
發(fā)表于 2025-3-26 03:49:40 | 只看該作者
Human Hepatic Stem/Progenitor Cells in Cancer and Liver Disease. The identification of hepatic stem/progenitor cells was first claimed in experimental animal models, while the chief support for their existence arises from several studies on cirrhosis, liver disease, and carcinogenesis. Liver stem/progenitor cells are typically characterized by the self-renewal
27#
發(fā)表于 2025-3-26 07:09:18 | 只看該作者
28#
發(fā)表于 2025-3-26 10:53:34 | 只看該作者
29#
發(fā)表于 2025-3-26 14:40:58 | 只看該作者
30#
發(fā)表于 2025-3-26 20:29:53 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 13:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
天全县| 平南县| 丹寨县| 墨玉县| 塔城市| 电白县| 江达县| 霸州市| 锦州市| 秭归县| 宝坻区| 华宁县| 兴化市| 定远县| 天水市| 邹城市| 察哈| 辛集市| 五华县| 赞皇县| 贵德县| 延津县| 梁平县| 中山市| 渭源县| 安徽省| 库车县| 健康| 丰镇市| 阳信县| 长寿区| 大名县| 青浦区| 县级市| 志丹县| 金秀| 本溪市| 宁安市| 哈密市| 澜沧| 哈巴河县|